Life stage
Perimenopause
The menopausal transition, characterized by hormonal fluctuation and changing symptoms.
Hormonal fluctuation during the menopausal transition may affect weight, bone turnover, and vasomotor symptoms. Evidence specific to perimenopausal use of GLP-1 agonists, GnRH analogs, or PTH peptides is sparse; most trials classify participants by age rather than menopausal stage.
Evidence gaps and exclusion patterns
- Hormonal interaction studies
- Symptom endpoints
Questions for clinician conversations
- What evidence exists for people in my life stage?
- What are the known unknowns for this medicine in this population?
- How should I monitor for adverse effects?
Medical disclaimer: Her Health Peptides publishes educational, source-linked summaries. We do not provide individualized medical advice, diagnosis, or treatment recommendations. Always talk with a licensed clinician about your specific situation, especially if you are pregnant, breastfeeding, planning pregnancy, or taking other medicines.